Innate vs Adaptive Immunity
โญ High-Yield Immunological Framework
7 Parameters
Innate Immunity vs Adaptive Immunity (Cardinal Comparison)
Comprehensive comparative matrix of response speed, specificity, memory formation, diversity, and cellular effectors.
| Feature | Innate Immunity | Adaptive Immunity |
|---|---|---|
| Response Kinetics | Immediate (minutes to hours) | Delayed (days to weeks upon primary exposure) |
| Specificity | Broadly specific for shared PAMPs (pathogen-associated molecular patterns) | Highly specific for individual unique molecular epitopes |
| Receptors Encoded By | Germline-encoded Pattern Recognition Receptors (TLRs, NLRs, RLRs) | Somatic V(D)J gene rearrangement (BCR / antibodies and TCR) |
| Immunological Memory | None (re-exposure produces identical response; trained immunity is epigenetic) | Robust lifelong memory (memory B & T cells cause faster, higher secondary response) |
| Diversity of Receptors | Limited (~10^3 germline pattern receptors) | Extremely vast (>10^11 distinct receptor combinations) |
| Key Cellular Components | Neutrophils, Macrophages, Dendritic cells, Natural Killer (NK) cells | B lymphocytes (plasma cells) and T lymphocytes (CD4+ Helper, CD8+ Cytotoxic) |
| Humoral Mediators | Alternative/Lectin Complement, Lysozyme, Interferons, C-reactive protein | Secreted antibodies (IgG, IgM, IgA, IgE, IgD), Classical Complement |
Response Speed & Specificity
Innate
Onset: Immediate (Hours)
Memory: No
Receptor Source: Germline PRRs
Adaptive
Onset: Delayed (Days)
Memory: Yes (Robust)
Receptor Source: V(D)J Recombination
Antigen Presentation & MHC
โญ Rule of 8 & Antigen Presentation
7 Parameters
MHC Class I vs MHC Class II Architecture & Processing Pathways
Structural polypeptide composition, peptide binding groove dimensions, antigen processing pathways, and coreceptor interaction rules.
| Feature | MHC Class I | MHC Class II |
|---|---|---|
| Polypeptide Chain Composition | One polymorphic ฮฑ chain (ฮฑ1, ฮฑ2, ฮฑ3) + non-covalent invariant ฮฒ2-microglobulin | Two polymorphic transmembrane chains: ฮฑ chain (ฮฑ1, ฮฑ2) and ฮฒ chain (ฮฒ1, ฮฒ2) |
| Peptide-Binding Groove | Formed by ฮฑ1 and ฮฑ2 domains; closed at both ends | Formed by ฮฑ1 and ฮฒ1 domains; open at both ends |
| Length of Bound Peptide | 8 โ 11 amino acids (short, constrained) | 13 โ 25+ amino acids (longer, can overhang edges) |
| Cellular Expression Profile | All nucleated cells and platelets (NOT on non-nucleated RBCs) | Professional Antigen-Presenting Cells (APCs: Dendritic cells, Macrophages, B cells) |
| Antigen Source & Processing Pathway | Endogenous (intracellular cytosolic proteins, viral or tumor antigens) | Exogenous (extracellular pathogens internalized via phagocytosis/endocytosis) |
| Degradation Machinery | Cytosolic 26S Proteasome โ TAP transporter into ER lumen | Endosomal/Lysosomal acid proteases (Cathepsins) |
| Effector T Cell Coreceptor | CD8+ Cytotoxic T Lymphocytes (CTLs) โ Target cell lysis (Perforin/Granzyme) | CD4+ T Helper Cells (Th1, Th2, Th17, Treg) โ Cytokine release |
The Rule of 8 Matrix
Key Point
Class: MHC Class I
Coreceptor: CD8+
Product Rule: 1 ร 8 = 8
Antigen Source: Endogenous (Cytosol)
Key Point
Class: MHC Class II
Coreceptor: CD4+
Product Rule: 2 ร 4 = 8
Antigen Source: Exogenous (Endosome)
Hypersensitivity & Tolerance
โญ Medical Immunology Master Matrix
4 Parameters
Gell & Coombs Hypersensitivity Reactions: Types I, II, III & IV
Exhaustive comparison of immunological mechanisms, antibody mediators, effector cells, onset times, and canonical clinical disease manifestations.
| Parameter | Type I (Immediate / Anaphylactic) | Type II (Cytotoxic / Antibody-Mediated) | Type III (Immune Complex) | Type IV (Delayed-Type / Cell-Mediated) |
|---|---|---|---|---|
| Primary Immune Mediator | IgE antibodies bound to FcฮตRI receptors | IgG and IgM antibodies against cell surface antigens | Circulating IgG/IgM immune complexes deposited in tissue | Sensitized T cells (CD4+ Th1/Th17 and CD8+ CTLs); NO antibodies |
| Effector Mechanism | Mast cell and basophil degranulation releasing histamine, leukotrienes | Complement-dependent cytotoxicity (MAC), ADCC (via NK cells), opsonization | Complement activation (C3a, C5a) recruiting neutrophils, releasing lysosomal enzymes | Macrophage activation via IFN-ฮณ; direct cytotoxic lysis via granzymes |
| Onset of Reaction | Minutes (15 โ 30 min; immediate wheal & flare) | Hours to days (cytolytic tissue destruction) | Hours (4 โ 10 hours; Arthus reaction) | Delayed: 24 โ 72 hours (peak at 48 hours) |
| Classic Disease Examples | Systemic anaphylaxis, allergic asthma, hay fever, peanut allergy | Autoimmune hemolytic anemia, Rh incompatibility (erythroblastosis fetalis), Goodpasture syndrome, Graves disease | Systemic Lupus Erythematosus (SLE), Post-streptococcal glomerulonephritis, Serum sickness | Tuberculin skin test (Mantoux), Contact dermatitis (poison ivy, nickel), Multiple Sclerosis, Type 1 Diabetes |
ACID Classification Rule
Type I (A)
Mediator: IgE
Effector: Mast Cells
Mnemonic: Anaphylactic
Type II (C)
Mediator: IgG / IgM
Effector: Complement / NK
Mnemonic: Cytotoxic
Type III (I)
Mediator: Immune Complexes
Effector: Neutrophils
Mnemonic: Immune Complex
Type IV (D)
Mediator: T Lymphocytes
Effector: Macrophages / CTLs
Mnemonic: Delayed
